- David Coldiron Joins CMTA Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the national patient advocacy organization leading CMT research, today announced the appointment of David Coldiron to its Board of Directors.Read more ... - A Message from Patients to Patients
As you’ll learn from watching this video by two young members of our CMT family, tiredness, exhaustion, fatigue and “sluggishness” are all part of having CMT.Read more ... - Another $500,000 Pledge to Type 2 Research!
Bruce Chizen, a special advisor to the Board of Directors, will match donations to CMT2 research on a one-to-one basis, up to $500,000.Read more ... - The 2019 Fall CMTA Report
The Type 2 Issue: We have set the stage for a number of Type 2 breakthroughs on our way to treatments for CMT.Read more ... - New Gene Therapy, Type 1/Type 4 Research Projects Approved
The CMTA today announced another $335,000 in grants to top CMT scientists leading the field in CMT Type 1 research. The grants cover work on types 1A, 1B and 1X and other demyelinating forms of CMT, including type 4.Read more ...
When you participate in the Walk 4 CMT campaign, you fund patient programs and treatment research initiatives to better the lives of the the 2.8 million people living with CMT.
In honor of CMTA Board Member Steve O'Donnell's quest for a CMT cure, the Plane Apparel Company will donate $5 from the purchase of each CMT Survivor Tee to the CMTA.